Search results
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
FOX 4 Kansas City· 2 days agoA total of 49 accepted abstracts and presentations will cover cutting-edge topics, including two...
Aster Insights, ORIEN to Present Research Abstracts at the 60th ASCO Annual Meeting
CBS 47 Fresno· 5 days agoFour abstracts examining melanoma, kidney, gastrointestinal, and uterine cancers highlight the work of collaborators across ORIEN, Aster Insights...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 2 days agoOncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024 American ...
AbelZeta Announces Publication of Abstract for ASCO 2024 Annual Meeting
Quincy Herald-Whig· 2 days ago...AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced that data from its C-CAR031 study has been published in an abstract available on the 2024 American...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 3 days agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology ...
IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2...
FOX 59 Indianapolis· 2 days ago~67% eye preservation rate (6 of 9 enucleation patients) with darovasertib monotherapy neoadjuvant uveal melanoma treatmentMedian tumor shrinkage (maximum volume change) of ~39% after 6 monthsClinical ...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 2 days agoBioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing...
Readers sound off on Muslims’ contributions, Black voters and municipal union leadership
New York Daily News· 2 hours agoAlso see the works of Abu-Kamil and al-Karaji. Abu Ali al-Hussain in Abdallah ibn Sina (Avicenna),...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 2 days agoWith its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A recent report from ...
